Leptabiside C is primarily investigated for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in inhibiting pro-inflammatory cytokines such as TNF-α and IL-6, making it a candidate for research in autoimmune and chronic inflammatory conditions, including rheumatoid arthritis and type 2 diabetes. Studies suggest it may also possess neuroprotective effects, supporting its exploration in neurodegenerative disease models. Additionally, Leptabiside C exhibits moderate antioxidant activity, which could contribute to cellular protection against oxidative stress. Preliminary studies have also explored its antimicrobial effects, particularly against certain fungal species, suggesting potential for development as an antifungal agent. Its application remains largely within preclinical research, focusing on drug discovery and development in natural product-based therapeutics.